Crelosidenib gentisate
Crelosidenib (gentisate) is a potent, selective and orally active mutant isocitrate dehydrogenase (IDH) inhibitor with IC50 of 6.27 nM, 3.71 nM, 36.9 nM and 11.5 nM for IDH1 R132H, IDH1 R132C, IDH2 R140Q and IDH2 R172K mutant enzymes, respectively. Crelosidenib (gentisate) is less active at inhibiting the IDH wild-type enzymes.
For research use only. We do not sell to patients.
- CAS No.: 2759438-85-0
- Formula: C42H48N6O11
- Molecular Weight:812.86
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
IDH1 |
IDH2 |
Chemical Information
-
CAS No. 2759438-85-0
-
Molecular Weight 812.86
-
Formula C42H48N6O11
-
SMILES
OC(C1=C(C=CC(O)=C1)O)=O.O=C2OCC3=CN=C(N=C3N2CC)N[C@@H](C)C(C=C4)=CC=C4[C@@H](N5CCN(CC5)C(C=C)=O)CC6CC6.OC(C7=C(C=CC(O)=C7)O)=O
-
Synonyms
LY3410738 gentisate; Mutant IDH1-IN-6 gentisate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)